In this open-label , randomised , phase @ trial , eligible patients were @ years , chemonave , East Asian , light ex-smokers/never-smokers with advanced non-squamous non-small cell lung cancer , an Eastern Cooperative Oncology Group ( ECOG ) performance status @-@ and unknown epidermal growth factor receptor ( EGFR ) mutation status who enrolled at @ sites in Asia .